These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 12825823

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neurologic improvement after high-dose intravenous immunoglobulin therapy in patients with paraneoplastic cerebellar degeneration associated with anti-Purkinje cell antibody.
    Phuphanich S, Brock C.
    J Neurooncol; 2007 Jan; 81(1):67-9. PubMed ID: 16773214
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Anti-Yo-associated paraneoplastic cerebellar degeneration in a man with gastric adenocarcinoma.
    Meglic B, Graus F, Grad A.
    J Neurol Sci; 2001 Apr 01; 185(2):135-8. PubMed ID: 11311295
    [Abstract] [Full Text] [Related]

  • 6. [Paraneoplastic cerebellar degeneration associated with ovarian cancer: anti-Yo immunoreactivity in autoptic cerebellum and ovarian carcinoma].
    Bartos A, Stourac P, Rusina R, Sejdová M, Velenská Z.
    Nervenarzt; 2002 Oct 01; 73(10):995-8. PubMed ID: 12376889
    [Abstract] [Full Text] [Related]

  • 7. Cytotoxic T cells against a peptide of Yo protein in patients with paraneoplastic cerebellar degeneration and anti-Yo antibody.
    Tanaka M, Tanaka K, Tokiguchi S, Shinozawa K, Tsuji S.
    J Neurol Sci; 1999 Sep 15; 168(1):28-31. PubMed ID: 10500270
    [Abstract] [Full Text] [Related]

  • 8. Anti-Yo positive paraneoplastic cerebellar degeneration associated with ovarian carcinoma: case report and review of the literature.
    Cao Y, Abbas J, Wu X, Dooley J, van Amburg AL.
    Gynecol Oncol; 1999 Oct 15; 75(1):178-83. PubMed ID: 10502450
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Paraneoplastic cerebellar degeneration (PCD) with anti-Yo antibodies in ovarian carcinoma].
    Holzmann P, Holy D, Stillhard G, Janda M, Möbr P.
    Schweiz Med Wochenschr; 1998 Jun 06; 128(23):906-8. PubMed ID: 9658519
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Restricted IgG1 subclass of anti-Yo antibodies in paraneoplastic cerebellar degeneration.
    Amyes E, Curnow J, Stark Z, Corlett L, Sutton I, Vincent A.
    J Neuroimmunol; 2001 Mar 01; 114(1-2):259-64. PubMed ID: 11240040
    [Abstract] [Full Text] [Related]

  • 16. [A case of paraneoplastic cerebellar degeneration associated with small cell lung cancer showing marked response to intravenous immunoglobulin].
    Kawakami M, Bando M, Mato N, Nakaya T, Ohno S, Sugiyama Y.
    Nihon Kokyuki Gakkai Zasshi; 2008 Apr 01; 46(4):325-30. PubMed ID: 18516998
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Paraneoplastic cerebellar degeneration--characterization of anti-Yo antibody and underlying cancer].
    Tanaka K, Tanaka M, Onodera O, Tsuji S.
    Rinsho Shinkeigaku; 1995 Jul 01; 35(7):770-4. PubMed ID: 8777801
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.